Abstract
Brain metastasis is a cause of grave morbidity and mortality in patients with a diagnosis of malignant melanoma. The reported incidence of brain metastasis in melanoma patients is highly variable: from 10-46% (in retrospective studies) and 30-92% (in autopsy series). Despite the fact that metastasis to brain is relatively common among this patient population, there exists no reliable method to predict the likelihood of this event in patients initially free of brain metastasis. However, we hypothesize that patient factors can predict the likelihood of brain metastases in patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
